Epidemic cerebrospinal meningitis immunological test

Epidemic cerebrospinal meningitis (meningoencephalitis) is still a common acute infectious disease that seriously threatens the health of children. The article describes the recent epidemic situation of meningoencephalitis in Africa, Europe, Oceania, the United States and China. The distribution of meningococcal serogroups, serotypes and serotypes in the above regions and countries, and meningococcal resistance to antibacterial drugs. In order to effectively control the epidemic of meningococci, monitoring and prevention of meningococci must be strengthened. To this end, it is proposed that in the monitoring of meningococcal epidemiology, not only the general incidence and mortality of meningococcus, but also its age group incidence rate. The changes in meningococcal serogroups and Antimicrobial resistance, as well as the carrier rate of the bacteria in healthy people and the antibody level of the population. Injecting children with meningococcal polysaccharide vaccine is the main measure to prevent meningococcal. In order to enhance the prevention of meningococcal polysaccharide vaccine for young children Effectively, some countries are using a conjugate vaccine prepared by combining group C meningococcal polysaccharide with a carrier protein.